| Mrs Ashley Renee' Arnett, CRNA | |
|
700 E Marshall Ave, Longview, TX 75601-5580 | |
| (903) 315-2000 | |
| Not Available |
| Full Name | Mrs Ashley Renee' Arnett |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 12 Years |
| Location | 700 E Marshall Ave, Longview, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316288632 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | AP123162 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christus Good Shepherd Medical Center | Longview, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christus Good Shepherd Medical Center | 3779565544 | 38 |
News Archive
A study published in the July 11 issue of the Annals of Internal Medicine suggests that people who drink coffee appear to have a longer life-span.
The vast majority of women in the menopause are familiar with the status of Red Clover as an herbal medicine that soothes hot flush symptoms and hormonal fluctuations.
Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.
Ipsen and Inspiration Biopharmaceuticals Inc. today announced they have entered into a strategic partnership agreement, to create a European hemophilia commercial organization, to launch Inspiration's hemophilia product portfolio in Europe.
Ivantis announced the enrollment of the first patient in the Hydrus IV study today. The Hydrus Microstent is the world's first intracanalicular scaffold for treatment of primary open angle glaucoma, a disease that afflicts over 70 million people worldwide and approximately 3 million people in the United States.
› Verified 4 days ago
| Entity Name | Longview Medical Center Lp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508824038 PECOS PAC ID: 2961490966 Enrollment ID: O20040505001835 |
News Archive
A study published in the July 11 issue of the Annals of Internal Medicine suggests that people who drink coffee appear to have a longer life-span.
The vast majority of women in the menopause are familiar with the status of Red Clover as an herbal medicine that soothes hot flush symptoms and hormonal fluctuations.
Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.
Ipsen and Inspiration Biopharmaceuticals Inc. today announced they have entered into a strategic partnership agreement, to create a European hemophilia commercial organization, to launch Inspiration's hemophilia product portfolio in Europe.
Ivantis announced the enrollment of the first patient in the Hydrus IV study today. The Hydrus Microstent is the world's first intracanalicular scaffold for treatment of primary open angle glaucoma, a disease that afflicts over 70 million people worldwide and approximately 3 million people in the United States.
› Verified 4 days ago
| Entity Name | Christus Good Shepherd Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760908404 PECOS PAC ID: 3779565544 Enrollment ID: O20040604000400 |
News Archive
A study published in the July 11 issue of the Annals of Internal Medicine suggests that people who drink coffee appear to have a longer life-span.
The vast majority of women in the menopause are familiar with the status of Red Clover as an herbal medicine that soothes hot flush symptoms and hormonal fluctuations.
Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.
Ipsen and Inspiration Biopharmaceuticals Inc. today announced they have entered into a strategic partnership agreement, to create a European hemophilia commercial organization, to launch Inspiration's hemophilia product portfolio in Europe.
Ivantis announced the enrollment of the first patient in the Hydrus IV study today. The Hydrus Microstent is the world's first intracanalicular scaffold for treatment of primary open angle glaucoma, a disease that afflicts over 70 million people worldwide and approximately 3 million people in the United States.
› Verified 4 days ago
| Entity Name | Texas Ams Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174926125 PECOS PAC ID: 9133441769 Enrollment ID: O20141209001912 |
News Archive
A study published in the July 11 issue of the Annals of Internal Medicine suggests that people who drink coffee appear to have a longer life-span.
The vast majority of women in the menopause are familiar with the status of Red Clover as an herbal medicine that soothes hot flush symptoms and hormonal fluctuations.
Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.
Ipsen and Inspiration Biopharmaceuticals Inc. today announced they have entered into a strategic partnership agreement, to create a European hemophilia commercial organization, to launch Inspiration's hemophilia product portfolio in Europe.
Ivantis announced the enrollment of the first patient in the Hydrus IV study today. The Hydrus Microstent is the world's first intracanalicular scaffold for treatment of primary open angle glaucoma, a disease that afflicts over 70 million people worldwide and approximately 3 million people in the United States.
› Verified 4 days ago
| Entity Name | Northstar Anesthesia Iii Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356968952 PECOS PAC ID: 0042630501 Enrollment ID: O20201022000080 |
News Archive
A study published in the July 11 issue of the Annals of Internal Medicine suggests that people who drink coffee appear to have a longer life-span.
The vast majority of women in the menopause are familiar with the status of Red Clover as an herbal medicine that soothes hot flush symptoms and hormonal fluctuations.
Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.
Ipsen and Inspiration Biopharmaceuticals Inc. today announced they have entered into a strategic partnership agreement, to create a European hemophilia commercial organization, to launch Inspiration's hemophilia product portfolio in Europe.
Ivantis announced the enrollment of the first patient in the Hydrus IV study today. The Hydrus Microstent is the world's first intracanalicular scaffold for treatment of primary open angle glaucoma, a disease that afflicts over 70 million people worldwide and approximately 3 million people in the United States.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ashley Renee' Arnett, CRNA 700 E Marshall Ave, Longview, TX 75601-5580 Ph: (903) 315-2000 | Mrs Ashley Renee' Arnett, CRNA 700 E Marshall Ave, Longview, TX 75601-5580 Ph: (903) 315-2000 |
News Archive
A study published in the July 11 issue of the Annals of Internal Medicine suggests that people who drink coffee appear to have a longer life-span.
The vast majority of women in the menopause are familiar with the status of Red Clover as an herbal medicine that soothes hot flush symptoms and hormonal fluctuations.
Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.
Ipsen and Inspiration Biopharmaceuticals Inc. today announced they have entered into a strategic partnership agreement, to create a European hemophilia commercial organization, to launch Inspiration's hemophilia product portfolio in Europe.
Ivantis announced the enrollment of the first patient in the Hydrus IV study today. The Hydrus Microstent is the world's first intracanalicular scaffold for treatment of primary open angle glaucoma, a disease that afflicts over 70 million people worldwide and approximately 3 million people in the United States.
› Verified 4 days ago
William W. Burlingame, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1907 Warwick Circle East, Longview, TX 75601 Phone: 903-757-4453 | |
Richard Klima, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 700 E Marshall Ave, Longview, TX 75601 Phone: 903-315-2000 | |
Eric Fernandez, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 6580 Judson Rd, Longview, TX 75605 Phone: 903-663-3600 | |
Randall Wayne Young, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 906 Judson Rd, Longview, TX 75601 Phone: 903-331-0506 Fax: 903-331-0462 | |
Mark D Bruce, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2901 N 4th St, Longview, TX 75605 Phone: 903-232-3606 Fax: 903-593-4290 | |
John Ryan Mccubbin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 140 Timber Falls Dr, Longview, TX 75605 Phone: 903-297-8640 | |
Kristy Dupus, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 6580 Judson Rd, Longview, TX 75605 Phone: 800-939-7440 |